Accelerate Diagnostics

company

About

Accelerate Diagnostics is an in vitro diagnostics company providing solutions to drug resistant organisms and hospital acquired infections.

  • 101 - 250

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
$45M
Industries
Consulting,Health Care,Health Diagnostics,Hospital,Information Technology
Founded date
Jan 1, 2004
Number Of Employee
101 - 250
Operating Status
Active

Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. It is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The Company’s revolutionary BACcel platform utilizes a proprietary culture-free process, with both genomic and phenotypic detection technologies, that significantly decreases time to result while achieving high sensitivity and specificity.

It was founded in 2004 and is headquartered in Tucson, Arizona.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$45M
Accelerate Diagnostics has raised a total of $45M in funding over 2 rounds. Their latest funding was raised on May 5, 2014 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 5, 2014 Post-IPO Equity $45M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Accelerate Diagnostics is funded by 2 investors. Oracle and Jack W. Schuler Living Trust are the most recent investors.
Investor Name Lead Investor Funding Round
Oracle Post-IPO Equity
Jack W. Schuler Living Trust Post-IPO Equity